RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER
description
Transcript of RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER
![Page 1: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/1.jpg)
RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY
GASTRIC CANCER
Professor Ravi KantFRCS (England), FRCS (Ireland),
FRCS(Edinburgh), FRCS(Glasgow), MS, DNB, FAMS, FACS, FICS,
Professor of Surgery
![Page 2: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/2.jpg)
2
DEFINITION
Early gastric cancer (EGC) is defined as tumour confined to mucosa & submucosa irrespective of lymph node involvement
Due to wide variation in the survival of lymph node + and – cases, the definition of EGC should be modified to gastric malignancy confined to the mucosa & submucosa without the involvement of lymph nodes.
Gastric Cancer 2000; 3:219-225
Br J Surg 1991; 78: 818-21.
![Page 3: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/3.jpg)
3
INCIDENCE
In Korea the incidence of EGC increased from 15% to 30% in 2 years from 1992 to 1994.
The percentage of EGC varies from 6 to 16% in western countries
This can be partly explained by the fact that Japanese include adenoma and dysplasia as a part of EGC
• World Journal of Surgery 1998; 22:1059
• Arch Surg 2000; 135: 1218-23.
![Page 4: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/4.jpg)
4
PROGNOSTIC FACTORS
The most important prognostic factor for EGC is the presence of lymph node metastasis.
Lymph node involvement in EGC depends upon the following factors
1. Tumour size2. Gross appearance3. Depth of invasion4. Histological pattern5. Lymphatic/vascular invasion
Ann Surg Oncol 1999; 6(7): 664-70
Int Surg 1998; 83(4): 287-90.
![Page 5: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/5.jpg)
5
PROGNOSTIC FACTORS Tumour size
Tumours smaller than 30mm. have a very low incidence of lymph node involvement.
As the diameter increases, they tend to be more undifferentiated, with significantly higher incidence of lymph node involvement.
Gastric Cancer 2000; 3:219-225.
Br J Surg 1998; 85: 835-39.
![Page 6: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/6.jpg)
6
PROGNOSTIC FACTORS Gross Appearance
The following tend to have a high rate of lymph node metastasis:
Type I and IIA lesions, depressed or mixed type
lesions, lesions with ulceration
World Journal of Surgery 1998; 22:1059
![Page 7: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/7.jpg)
7
PROGNOSTIC FACTORS Depth of invasion
The submucosa can be divided into 3 equal parts Sm1, Sm2 and Sm3.
incidence of lymph node metastasis varies from 2% to 12% and 20% according to the level of submucosa involved
Br J Surg 1991; 78: 818-21.
Br J Surg 1998; 85: 835-39.
![Page 8: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/8.jpg)
8
PROGNOSTIC FACTORS Histological pattern
The following have significantly higher rates of lymph node metastasis:
Undifferentiated carcinoma, diffuse type of malignancy and tumour with histological ulceration
Cancer 1999; 85(7): 1500-5
![Page 9: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/9.jpg)
9
PROGNOSTIC FACTORS Lymphatic invasion
The following are risk factors for lymph node involvement:
Large tumour size (>/= 30mm.) Involvement of lymphatic vessels Invasion of submucosal layer Poorly differentiated type Macroscopic depressed type Histological ulceration of the tumour Microscopically diffuse type Antral lesions Depressed/mixed type Type I and IIa
• Gastric Cancer 2001; 4: 34-38
![Page 10: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/10.jpg)
10
Lymph node distribution
Mainly group 1 location lymph nodes are involved in EGC and involvement of groups 2 and 3 is rare.
Sentinel lymph node involvement concept in gastric cancer has not yet been established
J Surg Oncol 1997; 64(1): 42-47
Surg Today 1997; 27: 600-605.
![Page 11: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/11.jpg)
11
DIAGNOSIS
To determine the depth of invasion and the
presence of lymph node metastasis, the
following investigations have been used:– Virtual Endoscopy – Magnifying Endoscopy – Fluorescence Endoscopy – Endoscopic Ultrasonography
Jr Comput Assist Tomogr 1998: 22: 709-713.
Am J Roentol. 1997; 169: 787-789.
![Page 12: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/12.jpg)
12
DIAGNOSISVirtual Endoscopy
using Helical CT system for 3D reconstruction with the volume rendering technique
Elevated lesions (EGC I and IIa) were better depicted rather than non-elevated lesions (EGC IIb and IIc).
Fine mucosal details, colour changes, textures and hyperaemia evident by conventional gastroscopy are not well depicted by Virtual Gastroscopy.
• Am J Roentol. 1997; 169: 787-789.
![Page 13: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/13.jpg)
13
DIAGNOSISMagnifying Endoscopy
Histopathological results were compared with findings of magnifying endoscopy regarding surface structures and microvessels.
There was a definitive correlation between the small, regular mucosal pattern of sulci and ridges and differentiated carcinoma.
Endoscopy 2004; 36(2): 165-169
.
![Page 14: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/14.jpg)
14
DIAGNOSISFluorescence Endoscopy
Exogenously applied sensitizers (5-aminolaevulanic acid) accumulate selectively in malignant lesions and induce fluorescence after illumination with light of adequate wavelength
Better detection of non-visible malignant or premalignant lesions
.
Dig Liver Dis 2002; 34(10): 754-761
![Page 15: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/15.jpg)
15
DIAGNOSISEndoscopic Ultrasonography
useful tool in differentiating early from late carcinoma of the stomach (accuracy of 91%)
low accuracy rate in differentiating between mucosal & submucosal cancer (accuracy rate 63.7%).
accuracy rates for detecting intramucosal cancer using endoscopy and endosonography were 84% and 78% respectively
Endoscopy 2002; 34(12): 973-978.
![Page 16: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/16.jpg)
16
CLINICAL PRESENTATION
Asymptomatic: The patient can be absolutely asymptomatic and malignancy picked up by mass screening or selective screening
Upper GI dyspepsia: Every patient who presents with dyspepsia after 50 years of age should undergo Upper GI endoscopy
Surgical Oncology 2000; 9: 17-22.
![Page 17: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/17.jpg)
17
Biochemical
Tumor MarkersCEA ▲ in 1/3 patients ≈ stageCEA + Ca 19-9 or CA 50
↑ sensitivity
![Page 18: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/18.jpg)
18
CA Stomach : significance of tumor marker
β HCG CA 125 CEA alpha fetoprotein CA 19-9, tissue staining for C - erb B 2
![Page 19: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/19.jpg)
19
CA 125, β HCG
Pre-op indicator of aggression tumor burden Prognostic
“Botet”
![Page 20: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/20.jpg)
20
Diagnosis
Auto-fluorescenceEndoscopic UltrasoundOptical Coherence
TomographyVirtual Biopsy
![Page 21: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/21.jpg)
21
Endoscopy
Size, location, morphology of lesion
Mucosal abnormality, bleedingProximal and distal spread of
tumorDistensibility
![Page 22: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/22.jpg)
22
Endoscopy
Abnormal motility ► SM infiltration, extramural extension – vagal infiltration
Bx–6 – 10 – 90% accuracy
Early Ca → 0.1% indigocarmine dye test
![Page 23: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/23.jpg)
23
![Page 24: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/24.jpg)
24
![Page 25: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/25.jpg)
25
EUS
Good for T & NNot good for M
Radial probes –7.5 or 12MHz better for Biopsy
![Page 26: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/26.jpg)
26
T 1
![Page 27: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/27.jpg)
27
T 2
![Page 28: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/28.jpg)
28
T 3
![Page 29: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/29.jpg)
29
![Page 30: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/30.jpg)
30
![Page 31: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/31.jpg)
31
![Page 32: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/32.jpg)
32
OCT / Virtual Biopsy
Optical coherence tomography
Beyond routine endoscopy
Differentiates - benign and malignant, mucosal dysplasias
![Page 33: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/33.jpg)
33
![Page 34: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/34.jpg)
34
![Page 35: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/35.jpg)
35
LIFE
Light Induced Fluorescence Endoscopy
Early detection of dysplasias and superficial malignant lesions, in situ Ca
![Page 36: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/36.jpg)
36
![Page 37: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/37.jpg)
37
![Page 38: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/38.jpg)
38
![Page 39: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/39.jpg)
39
![Page 40: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/40.jpg)
40
Contrast Radiography Motility – Ba meal, hypotonic
duodenography
Structural changes
Diagnostic accuracy: – Single – 80%– Double – 90%
![Page 41: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/41.jpg)
41
Computed TomographyAbdomen and chestLateral extension, Systemic mets-
75%Triphasic spiral CT – T stage,
stomach filled with water Tako et al 1998 – Adv gastric Ca – 82% Early Ca – 15%
![Page 42: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/42.jpg)
42
CT – T Staging
Gastric distensionDoes not differentiate T1 and T2T3 stranding in perigastric fatDoes not differentiate transmural
and perigastric lymphadenopathyAccuracy 80 – 88% in Advanced
disease
![Page 43: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/43.jpg)
43
![Page 44: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/44.jpg)
44
CT – N Staging
Size – no predictor of involvement> 8mm sensitivity – 48%,
specificity 93% Identifies distal nodes (not seen on
EUS)No of involved nodes N1 1 -6
RLN according to current TNM classification
![Page 45: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/45.jpg)
45
CT – M Staging
Liver mets – thin collimation, overlapping slides, dual phase imaging
75 – 80 % mets detected
Small volume ascites – EUS and CT
![Page 46: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/46.jpg)
46
Conventional US
Good clinical evidence of liver mets
When treatment options are limited – before palliation
Used in conjunction with or, alternative to MRI – indeterminate lesions on CT
![Page 47: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/47.jpg)
47
MRI
T assessment – No evidence that MRI better than CT
For identification of indeterminate lesions
IV contrast allergyEndoluminal MR – experimental
only and no advantage over EUS
![Page 48: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/48.jpg)
48
PET
FDG (fluorodeoxyglucose) 18 FPreferrential accumulation of PEG
in tumourSensitivity 60%, specificity 100%,
Accuracy 94%Detects 20% missed mets on CTDifferentiates: malignancy from
inflammation
![Page 49: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/49.jpg)
49
PET+CT Combo
![Page 50: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/50.jpg)
50
Laparoscopy
Peritoneal Disease M1 – CT, EUS, Small volume ascites
Routine use after CT / EUS before radical surgery
Additional information than CTComplementary to CT / EUSAccuracy 84%
![Page 51: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/51.jpg)
51
Laparoscopy US Probes
III dimension in US – detects unsuspected liver and lymphnode metastases
Eliminates need for laparotomy
![Page 52: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/52.jpg)
52
Mechanism of Photo-toxicity
Release of singlet oxygenS phase cells more vulnerable than
G phase cells
![Page 53: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/53.jpg)
53
![Page 54: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/54.jpg)
54
![Page 55: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/55.jpg)
55
![Page 56: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/56.jpg)
56
![Page 57: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/57.jpg)
57
![Page 58: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/58.jpg)
58
![Page 59: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/59.jpg)
59
![Page 60: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/60.jpg)
60
![Page 61: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/61.jpg)
61
Inside Story – Wonder Pill
Pill with a camera – M2 APictures taken at 2 frames per
secondMicrochip in camera with 8 hour
batteryReceiver in the beltAmbulatory endoscopic monitoring
![Page 62: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/62.jpg)
62
Camera Pill
![Page 63: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/63.jpg)
63
Rx EGC
1. Endoscopic
2. Laparoscopic
3. Conventional
• Surgical Oncology 2000; 9: 17-22.
![Page 64: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/64.jpg)
64
Endoscopic Rx
1. Strip Biopsy – using the grasp & pull technique with a double channel endoscope.
2. Aspiration Mucosectomy – using the cup & suction technique.
3. Resection using a double polypectomy snare
4. Resection with the combined use of highly concentrated saline & epinephrine.
• Gut 2001; 33: 709 – 718.
![Page 65: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/65.jpg)
65
Lap Rx
1. Laparoscopic wedge resection using lesion lifting method for tumours along the greater curvature or on the anterior wall
of the stomach.
2. Laparoscopic intragastric mucosal resection: For lesions of the posterior wall of the stomach and for lesions near the cardia or the pylorus. World J Surg 1999; 23: 187-
192.
![Page 66: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/66.jpg)
66
Conventional Rx
Since 1881 Billroth I gastrectomy has been the gold standard for the treatment of gastric cancer.
EGC has been safely and successfully managed by this conventional gastrectomy because perigastric lymph nodes are completely harvested by this technique.
• Gastric Cancer 1999; 2:230-234.
![Page 67: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/67.jpg)
67
TREATMENTNewer surgical management
1. Segmental gastrectomy
2. Proximal gastrectomy
3. Wedge resection
4. Pylorus-preserving distal gastrectomy
Br J Surg 1999; 86: 526-528.
![Page 68: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/68.jpg)
68
< 4 cm Tumor =Segmental gastrectomy
intra-operative endoscopy and frozen section analysis of the dissected perigastric lymph nodes is carried out.
If nodes are +, then the procedure is converted to a conventional gastrectomy with an extended lymphadenectomy.
If nodes are -, segmental gastrectomy with a tumour free resection margin of 2 cm is adequate
Br J Surg 1999; 86: 526-528.
![Page 69: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/69.jpg)
69
Newer surgical management Proximal gastrectomy
Proximal Gastrectomy (with jejunal interposition) was described by Takeshita et al for proximal 1/3 of the stomach
• Surgery 1997; 121: 278-286
![Page 70: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/70.jpg)
70
Newer surgical management Pylorus-preserving gastrectomy
for EGC in the middle stomach In this technique a pyloric cuff of 2 cm. is
preserved while the distal 2/3 of the stomach is removed
Advantages are decreased incidence of post-gastrectomy dumping syndrome and gall bladder stone formation. Weight recovery is better.
Sometimes emptying disturbances can be present which can be relieved by Cisapride.
• Surgery 1998; 123: 165-170.
• World J Surg 1998; 22: 35-41.
![Page 71: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/71.jpg)
71
Newer surgical managementLymph node management
No lymph node dissection is recommended for mucosal tumours
(the lymph node metastasis in mucosal gastric cancer only 2.4 % and preservation of regional lymph nodes may enhance post-operative immunocompetence.
Cancer 2000; 89: 1425-1430.
Am J Surg 2000; 180: 127-132.
![Page 72: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/72.jpg)
72
Newer surgical managementLymph node management
In patients with submucosal tumours, extended lymphadenectomy has been shown to prolong survival, especially when these tumours are located in the distal 1/3 of the stomach.
Cancer 2000; 89: 1425-1430.
Am J Surg 2000; 180: 127-132.
![Page 73: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/73.jpg)
73
PLANNING OF TREATMENT Endoscopic Mucosal Resection
(EMR) should be used initially for all patients with EGC
If histology reveals complete resection, the treatment is complete & only regular F/U reqd.
![Page 74: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/74.jpg)
74
Incomplete resection
–For mucosal tumours, Laparoscopic Local Resection
![Page 75: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/75.jpg)
75
Incomplete resection
– for mucosal tumours with ulceration or Sm 1a, Laparoscopy-Assisted Gastrectomy with D1 lymph
node dissection .
![Page 76: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/76.jpg)
76
Incomplete resection
– for Sm 1b, Gastrectomy with D2
lymph node dissection is indicated.
![Page 77: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/77.jpg)
77
Extent of lymph node dissection 1. Mucosal tumour < 30 mm: No
lymph node dissection required.
![Page 78: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/78.jpg)
78
Extent of lymph node dissection Mucosal tumour > 30 mm:
Dissection of local perigastric lymph nodes (D1) only.
![Page 79: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/79.jpg)
79
Extent of lymph node dissection
Submucosal tumour: D1 dissection along with dissection of lymph nodes along the left gastric artery, antero-superior common hepatic artery, celiac artery and proximal portion of the splenic artery.
![Page 80: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/80.jpg)
80
Survival rate for endoscopic mucosal resection(EMR)
98 patients who had successful EMR there was no tumor related deaths during a median follow up of period of 38 months.(Gut2001:48;225-9)
![Page 81: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/81.jpg)
81
Survival rate for Laparoscopic wedge resection
57 patients who had successful LAPAROSCOPIC WEDGE RESECTION , no patient died of disease during median follow up period of 65 months (World Journal of Surgery1999:23;187-92)
![Page 82: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/82.jpg)
82
SUMMARY
The incidence of EGC is on the rise because of aggressive screening by upper GI endoscopy.
Lymph node metastasis is the most important prognostic factor (has a higher recurrence rate and a significantly lower survival rate).
![Page 83: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/83.jpg)
83
SUMMARY
Incidence of lymph node metastasis is much higher in submucosal lesions.
![Page 84: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/84.jpg)
84
SUMMARY
Endoscopic ultrasonography has an important role in preoperative evaluation of lymph node metastasis and for differentiation between mucosal and submucosal lesions.
![Page 85: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/85.jpg)
85
SUMMARY
Endoscopic mucosal resection and Laparoscopic gastrectomy are two minimally invasive procedures which are becoming the standard of care for management of EGC.
![Page 86: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/86.jpg)
86
THANK YOU
![Page 87: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/87.jpg)
87
R1
R & L cardiac LNLN along lessor and greater
curvaturesupra and infra pyloric LN
![Page 88: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/88.jpg)
88
R2=R1+ LNs
along / at / aroundL gastric Acommon hepatic Acoeliac Asplenic hilumsplenic A.
![Page 89: RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER](https://reader035.fdocuments.in/reader035/viewer/2022062314/56813a5e550346895da253ec/html5/thumbnails/89.jpg)
89
R3 = R1 + R2 +LN
hepato-duodenal ligamentretropancreatico-duodenalroot of mesentriumMiddle colic A.Around abdominal aorta